Variables | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
HR (95%CI) | P | HR (95%CI) | P | ||
Age (years) | |||||
≤ 60 | Ref. | - | |||
> 60 | 1.128 (0.851–1.494) | 0.402 | |||
BMI | 0.99 (0.944–1.039) | 0.691 | |||
Tumor size (cm) | |||||
≤ 2.70 | Ref. | - | |||
2.70–4.40 | 0.954 (0.623–1.459) | 0.827 | |||
> 4.40 | 0.854 (0.556–1.312) | 0.473 | |||
Obstruction before surgery | |||||
Absent | Ref. | - | Ref. | - | |
present | 1.494 (1.05–2.124) | 0.025 | 1.734 (1.17–2.568) | 0.006 | |
Sex | |||||
Male | Ref. | - | |||
Female | 0.832 (0.627–1.104) | 0.202 | |||
Family history of cancer | |||||
No | Ref. | - | |||
Yes | 0.989 (0.629–1.555) | 0.962 | |||
Post radiotherapy | |||||
No | Ref. | - | |||
Yes | 0.735 (0.377–1.436) | 0.368 | |||
Adjuvant chemotherapy | |||||
No | Ref. | - | |||
Yes | 0.825 (0.624–1.091) | 0.178 | |||
Vascular cancer embolus | |||||
Absent | Ref. | - | Ref. | - | |
Present | 1.584 (1.189–2.109) | 0.002 | 1.244 (0.913–1.696) | 0.167 | |
Perineural invasion | |||||
Absent | Ref. | - | Ref. | - | |
Present | 1.506 (1.134–2.001) | 0.005 | 1.809 (1.353–2.419) | < 0.001 | |
Histological grade | |||||
Poorly | Ref. | - | Ref. | - | |
Moderately | 0.601 (0.429–0.84) | 0.003 | 0.689 (0.482–0.985) | 0.041 | |
Well | 0.66 (0.391–1.116) | 0.121 | 0.749 (0.44–1.275) | 0.287 | |
Stage | |||||
I | Ref. | - | |||
II | 2.481 (0.339–18.173) | 0.371 | |||
III | 5.86 (0.818–41.989) | 0.078 | |||
IV | 14.046 (1.945-101.454) | 0.009 | |||
T stage | |||||
T1 | Ref. | - | |||
T2 | 0.247 (0.041–1.477) | 0.125 | |||
T3 | 0.889 (0.22–3.596) | 0.869 | |||
T4 | 1.145 (0.281–4.667) | 0.850 | |||
N stage | |||||
N0 | Ref. | - | Ref. | - | |
N1 | 1.434 (1.005–2.048) | 0.047 | 1.314 (0.918–1.879) | 0.135 | |
N2 | 2.397 (1.698–3.383) | < 0.001 | 1.976 (1.373–2.844) | < 0.001 | |
M stage | |||||
M0 | Ref. | - | Ref. | - | |
M1 | 2.953 (2.145–4.066) | < 0.001 | 3.27 (2.319–4.611) | < 0.001 | |
Primary tumor location | |||||
Rectum | Ref. | - | |||
Right colon | 0.9 (0.627–1.292) | 0.567 | |||
Left colon | 1.109 (0.796–1.544) | 0.540 | |||
ASA | |||||
1 | Ref. | - | |||
2 | 0.61 (0.194–1.918) | 0.397 | |||
3 | 0.74 (0.229–2.389) | 0.614 | |||
4 | 0.825 (0.239–2.85) | 0.760 | |||
Previous history of abdominal surgery | |||||
No | Ref. | - | |||
Yes | 0.842 (0.579–1.223) | 0.366 | |||
Neoadjuvant chemotherapy | |||||
No | Ref. | - | |||
Yes | 1.159 (0.613–2.192) | 0.649 | |||
Preoperative comorbidities | |||||
Total patients | |||||
No | Ref. | - | |||
Yes | 1.238 (0.918–1.67) | 0.161 | |||
Cardiovascular disease | |||||
No | Ref. | - | |||
Yes | 1.227 (0.896–1.681) | 0.203 | |||
Cerebrovascular disease | |||||
No | Ref. | - | |||
Yes | 0.898 (0.37–2.184) | 0.813 | |||
COPD | |||||
No | Ref. | - | |||
Yes | 1.2 (0.493–2.916) | 0.688 | |||
Diabetes | |||||
No | Ref. | - | |||
Yes | 1.229 (0.726–2.082) | 0.442 | |||
CEA (ng/mL) | |||||
< 5 | Ref. | - | Ref. | - | |
≥ 5 | 1.839 (1.387–2.439) | < 0.001 | 1.52 (1.12–2.063) | 0.007 | |
CA199 (kU/L) | |||||
< 37 | Ref. | - | Ref. | - | |
≥ 37 | 1.517 (1.116–2.061) | 0.008 | 1.147 (0.825–1.596) | 0.414 | |
CA125 (U/mL) | |||||
< 35 | Ref. | - | Ref. | - | |
≥ 35 | 1.558 (1.044–2.326) | 0.030 | 1.193 (0.776–1.834) | 0.420 |